NCT00046020View on ClinicalTrials.gov

Study Evaluating Venlafaxine ER in Recurrent Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

1,096

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Depressive Disorder, MajorRecurrence
Interventions
DRUG

Venlafaxine ER

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00046020 - Study Evaluating Venlafaxine ER in Recurrent Depression | Biotech Hunter | Biotech Hunter